Clinical Trial Update: A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder. [Phase 3]

View source ↗

Summary

Phase 3 trial investigating ZX008 for CDKL5 Deficiency Disorder, evaluating efficacy and safety in subjects with CDKL5 Deficiency Disorder and related seizure t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cdkl5 Deficiency Disorder
• Epileptic Spasm
• Generalized Tonic Clonic Seizure
• Seizures

Drugs mentioned

• ZX008 (fenfluramine hydrochloride)

Snippet

Sponsor: Zogenix, Inc. | Conditions: CDKL5 Deficiency Disorder, Generalized Tonic Clonic Seizure | Phase 3 | Status: ACTIVE_NOT_RECRUITING